FDA Updates On Hyperinflation, Pancreatitis Risks Of Implantable Liquid-Filled Weight-Loss Balloons
Executive Summary
A letter from the US agency clarifies the risks of over-inflation, acute pancreatitis and death in patients who have been treated with liquid-filled intragastric balloons.
You may also be interested in...
Gastric Balloon Labeling Updated After Patient Deaths
US FDA has approved updated labeling for Orbera Intragastric Balloon System and the ReShape Integrated Dual Balloon System in the wake of five more patient deaths.
It’s A Class I Recall For Baxter’s WatchCare Device
Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting.
It’s A Class I Recall For Baxter’s WatchCare Device
Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting.